
Moderna doubles down on rare diseases; FDA advisory committee votes on fall Covid campaign; Illumina CEO steps down; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
As a reminder, the Endpoints team will be off on Monday. We’ll be back in your inbox on Tuesday, and keep an eye out for our virtual coverage of the 2023 Cannes Lions International Festival of Creativity. Pharma advertising award submissions surged almost 20% this year, and we’ll tell you all you need to know about this year’s winners. — Nicole DeFeudis
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.